The impact of psoriasis on health care costs and patient work loss.

Background: There are few comprehensive estimates of the cost of psoriasis in the United States.

Objective: We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis.

Methods: A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used.

The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective.

The goal of this study was to quantify the incremental direct medical and indirect work-loss costs associated with patients diagnosed with atopic dermatitis (AD). A de-identified administrative claims database was used comprising 5.1 million covered beneficiaries from 31 Fortune 500 self-insured employers between 1998 and 2005.